Research and Development Advisors

The Research and Development Advisors at DeuteRx play a crucial role in advancing the company's innovative approach to drug development. They leverage their expertise in Deuterium-Enabled Chiral Switching (DECS) to guide research initiatives and optimize the efficacy of racemic drugs, ensuring the delivery of safe and effective treatments for patients.